2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium
- 10 August 2015
- journal article
- conference paper
- Published by Wiley in Transfusion
- Vol. 55 (9) , 2282-2290
Abstract
On March 25 and 26, 2015, the National Heart, Lung, and Blood Institute sponsored a meeting on the State of the Science in Transfusion Medicine on the National Institutes of Health (NIH) campus in Bethesda, Maryland, which was attended by a diverse group of 330 registrants. The meeting's goal was to identify important research questions that could be answered in the next 5 to 10 years and which would have the potential to transform the clinical practice of transfusion medicine. These questions could be addressed by basic, translational, and/or clinical research studies and were focused on four areas: the three “classical” transfusion products (i.e., red blood cells, platelets, and plasma) and blood donor issues. Before the meeting, four working groups, one for each area, prepared five major questions for discussion along with a list of five to 10 additional questions for consideration. At the meeting itself, all of these questions, and others, were discussed in keynote lectures, small‐group breakout sessions, and large‐group sessions with open discourse involving all meeting attendees. In addition to the final lists of questions, provided herein, the meeting attendees identified multiple overarching, cross‐cutting themes that addressed issues common to all four areas; the latter are also provided. It is anticipated that addressing these scientific priorities, with careful attention to the overarching themes, will inform funding priorities developed by the NIH and provide a solid research platform for transforming the future practice of transfusion medicine.Keywords
Funding Information
- NIH
- NHLBI and by DHHS OASH
This publication has 55 references indexed in Scilit:
- Effect of a fixed-ratio (1:1:1) transfusion protocol versus laboratory-results–guided transfusion in patients with severe trauma: a randomized feasibility trialCanadian Medical Association Journal, 2013
- Hepcidin level predicts hemoglobin concentration in individuals undergoing repeated phlebotomyHaematologica, 2013
- Diagnostic randomized controlled trials: the final frontierTrials, 2012
- Increased Chest Tube Drainage Is Independently Associated With Adverse Outcome After Cardiac SurgeryJournal of Cardiothoracic and Vascular Anesthesia, 2012
- Iron deficiency in blood donors: the REDS‐II Donor Iron Status Evaluation (RISE) studyTransfusion, 2011
- Platelet storage and transfusions: New concerns associated with an old therapyDrug Discovery Today: Disease Mechanisms, 2011
- Development and Testing of Low-Volume Hyperoncotic, Hyperosmotic Spray-Dried Plasma for the Treatment of Trauma-Associated CoagulopathyJournal of Trauma: Injury, Infection & Critical Care, 2011
- Resuscitation and transfusion principles for traumatic hemorrhagic shockBlood Reviews, 2009
- Post‐transfusion mortality among recipients of ABO‐compatible but non‐identical plasmaVox Sanguinis, 2009
- A multicenter pilot‐randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantationTransfusion, 2007